Categories AlphaGraphs, Earnings, Health Care
Key highlights from CVS Health (CVS) Q2 2020 earnings results
CVS Health Corporation (NYSE: CVS) reported second quarter 2020 earnings results today.
Total revenues increased 3% to $65.3 billion, driven by growth across all segments.
The COVID-19 pandemic negatively affected results in the Pharmacy Services and Retail/LTC segments as new therapy prescriptions dropped due to lower provider visits.
Net income grew 54.6% to $2.9 billion, or $2.26 per share. Adjusted EPS totaled $2.64.
CVS raised its GAAP EPS guidance range to $5.59-5.72 from $5.47-5.60 and adjusted EPS guidance range to $7.14-7.27 from $7.04-7.17.
Past Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
